BTIG Cuts Veltassa Estimates, Relypsa's Price Target To $35
May 05, 2016 at 08:17 AM EDT
On its 1Q call, Relypsa Inc (NASDAQ: RLYP) highlighted the challenges it had been facing in gaining patient access for its hyperkalemia ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.